MedTrace Logo

Molecular Inflammation Board at the Center for Personalized Medicine

NCT07132333 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-08-20

No results posted yet for this study

Summary

Molecular Inflammation Board at the Center for Personalized Medicine

Conditions

  • Psoriasis (PsO)
  • Psoriasis Arthritis
  • Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
  • Spondylarthropathies

Interventions

BIOLOGICAL

Biologic Agent

Intervention with biologic agents

Sponsors & Collaborators

  • University Hospital Freiburg

    collaborator OTHER

  • University Hospital Heidelberg

    collaborator OTHER

  • University Hospital Ulm

    collaborator OTHER

  • University Hospital Tuebingen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-16
Primary Completion
2032-11-30
Completion
2032-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07132333 on ClinicalTrials.gov